Analysts Lift Targets Across Finance, Defence
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Analyst desks were broadly active on Wednesday, with upgrades and rising price targets spread across financial services, defence, and healthcare.
Northrop Grumman picked up a formal upgrade, pushing consensus to a more bullish split. The average target price moved to $629.83, up from $620.25. Defence spending optimism has supported the sector for months.
Capital One Financial saw its consensus target nudge to $252.00 from $250.48, as analysts continued to warm to the lender after a string of solid credit metrics. The stock carries 18 buy ratings and no sells.
Intuitive Surgical also got a target lift, with the consensus moving to $480.77. The robotic surgery firm holds 26 buy ratings, one of the most heavily backed calls in the medtech space.
Moderna bucked a tough stretch. Analysts raised the average target to $127.16 from $124.72. The stock carries a mixed consensus with 15 holds, but direction is improving.
On the downside, Align Technology saw its target trimmed to $191.64. The dental device maker has faced softer consumer spending.
Netflix also saw a small target cut to $88.73, though it still holds 34 buy ratings. The trim looks modest against a wall of bullish sentiment.
MSCI Inc. rounds out the upgrades, target rising to $677.94. Worth noting: ORTEX Index Rebalance Radar data shows $287.6 billion tracks the MSCI World, where a November quarterly review announcement falls on 11 November.
Stocks in this article
How this article was generated
- Generated
- 21 Oct 2026, 16:20
- Prompt version
- v1.0
- Data sources
- Analyst consensusAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.